PTC Therapeutics | PTCT - Ebitda

Stock Price
68.23
Daily Change
-0.36 -0.52%
Monthly
2.22%
Yearly
37.75%
Q2 Forecast
66.77

PTC Therapeutics reported $-70.99M in EBITDA for its fiscal quarter ending in December of 2025.





Ebitda Change Date
Acadia Pharmaceuticals USD 35.76M 447K Sep/2025
Alnylam Pharmaceuticals USD 145.22M 236.56M Dec/2025
Amgen USD 5.14B 775M Dec/2025
BioCryst Pharmaceuticals USD 51.7M 30.14M Sep/2025
Biogen USD 573.2M 253.7M Dec/2025
BioMarin Pharmaceutical USD -24.17M 18.91M Dec/2025
Cytokinetics USD -277.18M 169.36M Sep/2025
Daiichi Sankyo JPY 101.6B 22.81B Mar/2025
Esperion Therapeutics USD -9.93M 24.99M Sep/2025
Gilead Sciences USD 3.02B 1.01B Dec/2025
Incyte USD 414.5M 92.42M Dec/2025
Ionis Pharmaceuticals USD -157.12M 307.36M Sep/2025
Ironwood Pharmaceuticals USD 81.81M 31.71M Sep/2025
Karyopharm Therapeutics USD -26.2M 1.83M Sep/2024
Novartis USD 4.77B 1.11B Dec/2025
Pfizer USD 6.08B 351M Sep/2025
PTC Therapeutics USD -70.99M 91.62M Dec/2025
Puma Biotechnology USD 729K 11.36M Jun/2024
Roche Holding CHF 12.68B 2.36B Jun/2024
Sarepta Therapeutics USD -168.03M 294.45M Sep/2025
TG Therapeutics USD 32.69M 5M Sep/2025
Ultragenyx Pharmaceutical USD -156.79M 65.44M Sep/2025
Vertex Pharmaceuticals USD 1.44B 100.4M Sep/2025
Xencor USD -51.05M 55.28M Dec/2025